VISN 20 POC whole blood glucose testing analyzers BPA

Ended Awarded Last action

Contract number
36C26022N0201
Awardee
Awarding agency
Obligated
$44,494

Award facts

Contract value 100% obligated
$44,493.82 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$127,671
Original award $172,165

About this award

This is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract, valued at $44,493.82, is for the provision of whole blood glucose testing analyzers for the VA's Veterans Integrated Service Network (VISN) 20. The contract does not have a set-aside designation, indicating it was awarded through open competition. Roche Diagnostics is a global leader in diagnostic solutions and has multiple significant contract vehicles with federal agencies, including the Defense Health Agency and VA, for a wide range of medical diagnostic equipment, reagents, and services. This BPA is established under the General Services Administration (GSA) Schedule for In Vitro Diagnostics, Reagents, and Test (FSS-65-VII), allowing the VA to efficiently acquire Roche's diagnostic technologies through pre-negotiated pricing and terms.

Quick answers

Who was awarded contract 36C26022N0201?

36C26022N0201 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 20 (Veterans Health Administration) on January 15, 2022.

How much is contract 36C26022N0201 worth?

The government has obligated $44,494 on 36C26022N0201. Its current value, with exercised options, is $44,494.

Is contract 36C26022N0201 an order under another contract?

Yes. 36C26022N0201 is a BPA call under V797P5279B-36C26019A0034, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract 36C26022N0201 competed?

The extent of competition for 36C26022N0201 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award